Livafin Cream contains Amorolfine 0.25% w/w, an antifungal agent primarily indicated for the treatment of superficial fungal infections of the skin and nails. Amorolfine belongs to the morpholine class of antifungals and exerts its effect by inhibiting fungal sterol biosynthesis, thereby disrupting the cell membrane integrity and leading to fungal cell death. Livafin Cream is effective against dermatophytes, yeasts, and molds responsible for conditions such as athlete’s foot, ringworm, and candidiasis. The topical formulation allows for targeted application, minimizing systemic absorption and associated side effects. It is typically applied once or twice daily to the affected area after cleansing and drying the skin, with treatment duration varying depending on the severity and type of infection. Common adverse effects may include mild local irritation, redness, or itching at the site of application, which are generally transient. Livafin Cream should be used with caution in patients with known hypersensitivity to amorolfine or any cream excipients. It is not recommended for use on mucous membranes or in cases of extensive skin involvement without medical supervision. As with all antifungal therapies, adherence to the prescribed regimen is essential to ensure effective eradication of the infection and to prevent recurrence.